Document Type
Article
Date of Original Version
2019
Department
Pharmacy Practice
Abstract
Malignant mesothelioma is a rare and devastating form of cancer with an increasing economic burden. We sought to describe the direct cost burden of mesothelioma to the US health system. A systematic literature review was performed to locate published estimates of the medical cost of mesothelioma. In addition, we performed an analysis of hospital discharge data from the National Inpatient Sample, Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. We also reviewed publicly available legal settlements. We found that published estimates of the cost of medical care for mesothelioma are sparse, and differ with respect to nation, timeframe, and types of cost included. For the year 2014 in the United States, we estimated a mean cost per mesothelioma hospitalization of US$24,124 (95% confidence interval: US$20,819–US$28,983) and a total cost for hospital care of US$44,214,835. In conclusion, we found that reports describing the direct medical cost of care for mesothelioma in the United States are lacking, yet the per-patient cost of care is substantial, as evidenced by analyses of inpatient care and legal settlements.
Citation/Publisher Attribution
Borrelli, E., Babcock, Z., & Kogut, S. (2019) Costs of medical care for mesothelioma. Rare Tumors, 11, 1-8. doi: 10.1177/2036361319863498
Available at: https://doi.org/10.1177/2036361319863498
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License